We’re excited to be in Boston this week at the kickoff of the 25th 2018 BIO International Convention. 

Today, our executive vice president & chief operating officer Charl Van Zyl joined the BIO board as UCB’s representative. “UCB is proud to be a BIO member supporting innovation and patient value throughout the healthcare ecosystem. We are pleased to be a part of the 25th year of this important industry event,” said Charl. 

If you’re in Boston, we hope you take a moment to stop by the UCB booth, #1743 in the Belgium Pavilion. Or, find us on Wednesday, as UCB Health Economics and Outcomes Research expert Eddie Lee shares his insight on the new role of value assessment frameworks.
 

• Weds., June 6, 1:45 p.m. to 2:45 p.m. EST - Panel: New Role for Value Assessment Frameworks in the U.S., in Room 210A, Level 2: As part of the Value, Patient Access & Reimbursement Track – which UCB is proud to support – the panel session will explore the current landscape of value assessment frameworks in the U.S., how they are evolving, and what this means for patients’ access to medicines. 

Eddie will discuss UCB’s approach to value assessment frameworks and how we can use these frameworks to help us evaluate and capture what patients value so we can ensure that the right patient can get the right solution at the right time.
 
We hope to see you in Boston at #BIO2018!